Similar articles

• Therapeutic interventions in primary HIV infection.

  Kinloch-de Loës S, Perrin L. Kinloch-de Loës S, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 1:S69-76. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 8595514 Review. No abstract available.
• [Causal therapy possibilities in HIV infections].

  Baumgarten R. Baumgarten R. Dermatol Monatsschr. 1989;175(8):469-73. Dermatol Monatsschr. 1989. PMID: 2676627 Review. German.
• [Therapeutic drugs--rarely causal therapy].

  Uhl D. Uhl D. Med Monatsschr Pharm. 1990 May;13(5):129. Med Monatsschr Pharm. 1990. PMID: 2192241 German. No abstract available.
• [Pathogenesis of HIV infection as the key to eradication? New therapeutic approaches].

  Manegold C. Manegold C. MMW Fortschr Med. 2000 Mar 13;142 Suppl 1:34-9. MMW Fortschr Med. 2000. PMID: 10863308 German.
• Chemotherapy of human immunodeficiency virus (HIV) infection: anti-HIV agents targeted at early stages in the virus replicative cycle.

  De Clercq E. De Clercq E. Biomed Pharmacother. 1996;50(5):207-15. doi: 10.1016/0753-3322(96)87660-8. Biomed Pharmacother. 1996. PMID: 8949401 Review.